Furthermore, NF-κB is activated in virtually all chronic liver diseases, including ALD, NAFLD, viral hepatitis, and biliary liver disease [101,102,103]. This evidence concerns the gene NFKB1 and metabolic dysfunction-associated steatotic liver disease.